Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Sudabeh, Alatab"'
Autor:
Shaghayegh Khanmohammadi, Ali Sheidaei, Sudabeh Alatab, Ozra Tabatabaei-Malazy, Homayoon Vahedi, Fariborz Mansour-Ghanaei, Hafez Fakheri, Farshad Sheikhesmaeili, Anahita Sadeghi, Ali Reza Sima, Amir Anushiravan, Abbas Yazdanbod, Seyed Hamid Moosavy, Iradj Maleki, Hassan Vosooghinia, Masoud Malekzadeh, Reza Malekzadeh
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0304792 (2024)
BackgroundDespite the rising prevalence of Inflammatory Bowel Disease (IBD), age and sex differences in its outcomes remain understudied. We investigated age and sex differences in IBD patients using a nationwide study in Iran, the Iranian Registry o
Externí odkaz:
https://doaj.org/article/87c49c35a8a641bdad59d39116bb276b
Autor:
Soroush Moradi, Amirhossein Parsaei, Sahar Saeedi Moghaddam, Armin Aryannejad, Sina Azadnajafabad, Negar Rezaei, Baharnaz Mashinchi, Zahra Esfahani, Parnian Shobeiri, Nazila Rezaei, GBD 2019 Iran MRF Collaborators, Mohsen Naghavi, Bagher Larijani, Farshad Farzadfar, Amirali Aali, Mohsen Abbasi-Kangevari, Zeinab Abbasi-Kangevari, Shima Abdollahi, Abdorrahim Absalan, Siamak Afaghi, Ali Ahmadi, Amir Moghadam Ahmadi, Sepideh Ahmadi, Marjan Ajami, Meisam Akhlaghdoust, Sudabeh Alatab, Yousef Alimohamadi, Mehrdad Amir-Behghadami, Sohrab Amiri, Davood Anvari, Jalal Arabloo, Elaheh Askari, Shamsadin Athari Seyyed, Abolfazl Avan, Samad Azari, Hassan Babamohamadi, Nayereh Baghcheghi, Sara Bagherieh, Prof Hamid Reza Baradaran, Azadeh Bashiri, Mostafa Dianatinasab, Shirin Djalalinia, Milad Dodangeh, Mahsa Dolatshahi, Sareh Edalati, Hossein Farrokhpour, Ali Fatehizadeh, Fataneh Ghadirian, Ahmad Ghashghaee, Ali Gholami, Pouya Goleij, Nima Hafezi-Nejad, Hamidreza Hasani, Soheil Hassanipour, Mahsa Heidari-Foroozan, Kamran Hessami, Kaveh Hosseini, Mohammad-Sala Hosseini, Seyed Kianoosh Hosseini, Soodabeh Hoveidamanesh, Farideh Iravanpour, Rana Irilouzadian, Zahra Jamalpoor, Tannaz Jamialahmadi, Ali Kabir, Neda Kaydi, Sina Kazemian, Mohammad Keykhaei, Morteza Abdullatif Khafaie, Shaghayegh Khanmohammadi, Sorour Khateri, Farzad Kompani, Hamid Reza Koohestani, Prof Soleiman Mahjoub, Prof Ata Mahmoodpoor, Marzieh Mahmoudimanesh, Prof Elaheh Malakan Rad, Mohammad-Reza Malekpour, Prof Reza Malekzadeh, Mohammad Ali Mansournia, Abdoljalal Marjani, Esmaeil Mohammadi, Sara Momtazmanesh, Maryam Moradi, Maziar Moradi-Lakeh, Farhad Moradpour, Negar Morovatdar, Seyed Aria Nejadghaderi, Maryam Noori, Prof Hasti Nouraei, Ali Nowroozi, Hassan Okati-Aliabad, Prof Akram Pourshams, Mehran Rahimi, Shayan Rahmani, Vahid Rahmanian, Sina Rashedi, Mohammad-Mahdi Rashidi, Iman Razeghian-Jahromi, Malihe Rezaee, Leila Sabzmakan, Erfan Sadeghi, Prof Masoumeh Sadeghi, Saeid Sadeghian, Amirhossein Sahebkar, Hamideh Salimzadeh, Saman Sargazi, Prof Nizal Sarrafzadegan, Sadaf G Sepanlou, Melika Shafeghat, Mahan Shafie, Ataollah Shahbandi, Fariba Shahraki-Sanavi, Mehran Shams-Beyranvand, Athena Sharifi-Razavi, Seyed Afshin Shorofi, Seyed-Amir Tabatabaeizadeh, Alireza Tahamtan, Majid Taheri, Seyed Mohammad Vahabi, Prof Siavash Vaziri, Fereshteh Yazdanpanah, Mazyar Zahir, Moein Zangiabadian, Iman Zare, Zahra Zareshahrabadi, Prof Mohsen Naghavi, Prof Bagher Larijani, Prof Farshad Farzadfar
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionMetabolic risk factors (MRFs) predispose populations to a variety of chronic diseases with a huge burden globally. With the increasing burden of these risk factors in Iran, in this study, we aimed to report the estimated burden attributed
Externí odkaz:
https://doaj.org/article/1e37567a29a14ab2b5badb8a5069833e
Autor:
Seyed Aria Nejadghaderi, Sahar Saeedi Moghaddam, Mohammad Keykhaei, Parnian Shobeiri, Negar Rezaei, Nazila Rezaei, GBD 2019 Iran Kidney Dysfunction Collaborators, Mohsen Naghavi, Bagher Larijani, Farshad Farzadfar, Seyed Aria Nejadghader, Ashkan Abdollahi, Ali Ahmadi, Sepideh Ahmadi, Sudabeh Alatab, Jalal Arabloo, Mohammad Arjomandzadegan, Seyyed Shamsadin Athari, Sina Azadnajafabad, Mohammadreza Azangou-Khyavy, Nayereh Baghcheghi, Sara Bagherieh, Shirin Barati, Azizallah Dehghan, Ali Fatehizadeh, Fataneh Ghadirian, Maryam Gholamalizadeh, Ali Gholami, Kimiya Gohari, Hadi Hassankhani, Mohammad Jokar, Fatemeh khorashadizadeh, Farzad Kompani, Hamid Reza Koohestani, Soleiman Mahjoub, Ata Mahmoodpoor, Elaheh Malakan Rad, Mohammadreza Mobayen, Esmaeil Mohammadi, Yousef Moradi, Negar Morovatdar, Maryam Noori, Hassan Okati-Aliabad, Ghazaleh Pourali, Quinn Rafferty, Sina Rashedi, Mahsa Rashidi, Mohammad-Mahdi Rashidi, Amirhossein Sahebkar, Seyed Afshin Shorofi, Seyyed Mohammad Tabatabaei, Majid Taheri, Amir Taherkhani, Mazyar Zahir, Moein Zangiabadian, Iman Zare
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
BackgroundKidney dysfunction is a risk factor for cardiovascular disease and chronic kidney disease. Herein, we aimed to describe the attributable burden of kidney dysfunction at the national and sub-national levels in Iran.MethodsThe Global Burden o
Externí odkaz:
https://doaj.org/article/349d286840184130aa37aadc89abefeb
Autor:
Saba Alvand, Farhad Abolnezhadian, Sudabeh Alatab, Zahra Mohammadi, Fatemeh Hayati, Mohammad Noori, Leila Danehchin, Yousef Paridar, Bahman Cheraghian, Zahra Rahimi, Sanam Hariri, Sahar Masoudi, Seyed Ali Mard, Ali Akbar Shayesteh, Hossein Poustchi
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Chronic kidney disease (CKD) is a growing global health problem with faster progression in developing countries such as Iran. Here we aimed to evaluate the prevalence and determinants of CKD stage III+. Methods This research is pa
Externí odkaz:
https://doaj.org/article/aeec9f0c3cc64685a7b4e5ff5b692bba
Autor:
Masoud M Malekzadeh, Alireza Sima, Sudabeh Alatab, Anahita Sadeghi, Nasser Ebrahimi Daryani, Payman Adibi, Iradj Maleki, Hassan Vossoughinia, Hafez Fakheri, Abbas Yazdanbod, Seyed Alireza Taghavi, Rahim Aghazadeh, Mohammad Hassan Somi, Kazem Zendedel, Homayoon Vahedi, Reza Malekzadeh
Publikováno v:
Intestinal Research, Vol 17, Iss 3, Pp 330-339 (2019)
Background/Aims A recent study revealed increasing incidence and prevalence of inflammatory bowel disease (IBD) in Iran. The Iranian Registry of Crohn’s and Colitis (IRCC) was designed recently to answer the needs. We reported the design, methods o
Externí odkaz:
https://doaj.org/article/d500c9c584284f45aba9891886ec11a9
Autor:
Sudabeh Alatab, Soroosh Shekarchian, Iraj Najafi, Reza Moghadasali, Naser Ahmadbeigi, Mohammad Reza Pourmand, Tina Bolurieh, Neda Jaroughi, Gholamreza Pourmand, Nasser Aghdami
Publikováno v:
Cell Journal, Vol 20, Iss 4, Pp 483-495 (2018)
Using mesenchymal stem cells (MSCs) is regarded as a new therapeutic approach for improving fibrotic diseases. The aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs (AD-MSCs) in
Externí odkaz:
https://doaj.org/article/366f2bbb82eb4bd8935f1664b8156201
Publikováno v:
Case Reports in Clinical Practice, Vol 4, Iss 3 (2019)
Gout is a type of inflammatory arthritis that results from the deposition of monosodium urate crystals in the articular or periarticular tissues. In this educational case, we report a middle- aged man who presented with multiple nodules distributed b
Externí odkaz:
https://doaj.org/article/e07ef7e395de40379cf36ec842694d1b
Autor:
Amir, Anushiravani, Bahar, Saberzadeh-Ardestani, Homayoon, Vahedi, Hafez, Fakheri, Fariborz, Mansour-Ghanaei, Iraj, Maleki, Siavosh, Nasseri-Moghaddam, Hasan, Vosoghinia, Mohammad Reza, Ghadir, Ahmad, Hormati, Amir, Kasaeian, Amir Reza, Radmard, Bardia, Khosravi, Masoud, Malekzadeh, Sudabeh, Alatab, Anahita, Sadeghi, Nayyereh, Aminisani, Hossein, Poustchi, Ali Reza, Sima, Reza, Malekzadeh
Publikováno v:
Middle East Journal of Digestive Diseases. 14:182-191
BACKGROUND: Immunosuppressive agents used in the treatment of inflammatory bowel diseases (IBDs) could potentially increase the risk of coronavirus disease 2019 (COVID-19). We aimed to compare COVID-19 frequency in patients with IBD with their househ
Publikováno v:
Environmental Monitoring and Assessment. 195
Autor:
Sudabeh Alatab, Gholamreza Pourmand
Publikováno v:
Tehran University Medical Journal, Vol 73, Iss 8, Pp 545-553 (2015)
Thymoglobulin is a purified polyclonal immunoglobulin that has been used widely over the last decades in the prevention and treatment of rejection following renal transplantation. This immunoglobulin works against human thymocytes. Since thymoglobuli
Externí odkaz:
https://doaj.org/article/100cad975f024cf48c29ee663724d46c